University of Bristol

Living DNA can break down the origins of a customer’s ancestry into 21 distinct regions within Britain alone, as well as across 80 different worldwide populations.

University of Bristol researchers examine the Phormidesmis priestleyi BC1401 genome, a bacterium from the Greenland Ice Sheet.

In Genome Biology this week: computational approach to tease apart clonal tumor lineages, cell type-specific lncRNA expression in developing human neocortex, and more.

Expanding on past genome-wide association data, two teams delved into functional and phenotypic studies related to known schizophrenia-associated variants.

Ten new atopic dermatitis risk loci turned up in a genome-wide association study meta-analysis involving hundreds of thousands of individuals.

NEW YORK (GenomeWeb News) – Affymetrix and the UK's University of Bristol have partnered to develop a wheat genotyping array to be used in efforts to study wheat genetics and in breeding programs, Affymetrix said today.

NEW YORK (GenomeWeb News) - In Lancet Respiratory Medicine, an international team led by investigators at the Duke University Medical Center described findings from a prospective study looking at asthma-related information that can be

NEW YORK (GenomeWeb News) – The University of Bristol has announced that it plans to open a new £23million ($34.8 million) epidemiological research center that will harness an array of disciplines including genetics, epigenetics, computer sciences, chemistry, psychology, and others.

The Crop Improvement Research Club, a partnership between the BBSRC, Scotland, and industry, has awarded the first of two planned funding tranches totaling $11.3 million.

A UK consortium will use the funds to study wheat variations that could be used to develop more sustainable, higher-yielding crops.

Pages

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.